Stryker stock skidded Wednesday — despite reporting solid 10% organic sales growth — due to lighter-than-expected revenue from knee replacements. Please watch the video at Investors.com - How ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

Stryker Corporation SYK reported fourth-quarter 2024 adjusted earnings per share (EPS) of $4.01, which beat the Zacks ...

Analyst Patrick Wood from Morgan Stanley maintained a Buy rating on Stryker (SYK – Research Report) and keeping the price target at ...

which revolutionized knee surgeries. A key driver of Stryker’s success is its continuous focus on innovation. The Mako system, which combines 3D CT-based planning with real-time feedback ...

Stryker Corp. is a medical technology company ... The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical ...

Stryker (NYSE:SYK – Get Free Report) is expected to be releasing its earnings data after the market closes on Tuesday, ...

Ameritas Advisory Services LLC lowered its position in shares of Stryker Co. (NYSE:SYK – Free Report) by 33.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities & ...